Cargando…
SC66 inhibits the proliferation and induces apoptosis of human bladder cancer cells by targeting the AKT/β‐catenin pathway
Bladder cancer (BC) is a major disease of the genitourinary tract, and chemotherapy is one of the main treatments commonly used at present. SC66 is a new type of allosteric AKT inhibitor that is reported to play an effective inhibitory role in the progression of many other types of tumours, but ther...
Autores principales: | Chen, Wu, Zhao, Sheng, Yu, Weimin, Rao, Ting, Ruan, Yuan, Zhu, Shaoming, Xia, Yuqi, Song, Hongfei, Cheng, Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581318/ https://www.ncbi.nlm.nih.gov/pubmed/34687144 http://dx.doi.org/10.1111/jcmm.17005 |
Ejemplares similares
-
AKT Inhibitor SC66 Inhibits Proliferation and Induces Apoptosis in Human Glioblastoma Through Down-Regulating AKT/β-Catenin Pathway
por: Gao, Lun, et al.
Publicado: (2020) -
Targeting Akt by SC66 triggers GSK-3β mediated apoptosis in colon cancer therapy
por: Liu, Yeying, et al.
Publicado: (2019) -
Nanog and β-catenin: A new convergence point in EpSC proliferation and differentiation
por: YIN, DELONG, et al.
Publicado: (2011) -
Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells
por: Cusimano, Antonella, et al.
Publicado: (2014) -
IC-2 Suppresses Proliferation and Induces Apoptosis of Bladder Cancer Cells via the Wnt/β-Catenin Pathway
por: Wu, Lingfeng, et al.
Publicado: (2018)